Insider Transactions
Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Apr 25, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 418 | -- | -- | |
Apr 23, 2012 | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,091 | -- | -- | ||
Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.